Related Experiment Video
Updated: Apr 4, 2026

Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles
Published on: December 31, 2019
Sulfotransferase 1A1 Substrate Selectivity: A Molecular Clamp Mechanism
Ian Cook1, Ting Wang1, Thomas S Leyh1
1Department of Microbiology and Immunology, Albert Einstein College of Medicine , 1300 Morris Park Avenue, Bronx, New York 10461-1926, United States.
Human cytosolic sulfotransferases (SULTs) like SULT1A1 modify metabolites and toxins. This study reveals SULT1A1 substrates fall into two classes based on how nucleotide binding affects their affinity and catalytic efficiency.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- Human cytosolic sulfotransferases (SULTs) catalyze sulfuryl group transfer from PAPS to diverse substrates.
- SULT1A1, abundant in the liver, plays a key role in metabolizing endogenous compounds and detoxifying xenobiotics.
- Understanding SULT1A1 substrate selectivity is crucial for its biological and pharmacological relevance.
Purpose of the Study:
- To investigate the differential effects of nucleotide binding on SULT1A1 substrate affinity and catalytic activity.
- To elucidate the molecular mechanism underlying SULT1A1 substrate selectivity.
Main Methods:
- Enzyme kinetics assays to determine substrate affinity (Km) and catalytic rates (kcat).
- All-atom molecular dynamics simulations to model enzyme-substrate interactions.
- Analysis of point mutants to validate proposed catalytic mechanisms.
Main Results:
- SULT1A1 substrates were classified into positive-synergy and neutral-synergy groups based on nucleotide presence.
- Positive-synergy substrates exhibited significantly enhanced affinity (∼20-fold) and catalytic efficiency (∼3 orders of magnitude).
- Molecular dynamics revealed repositioning of phenylalanine residues (F81, F84) for positive-synergy substrates, facilitating catalysis, while neutral-synergy substrates showed less defined active site positioning.
Conclusions:
- SULT1A1 exhibits distinct substrate classes with differential responses to nucleotide binding, impacting catalytic efficiency.
- A molecular mechanism involving phenylalanine residue repositioning explains the enhanced affinity and catalysis for positive-synergy substrates.
- These findings provide insights into SULT1A1's broad substrate specificity and catalytic regulation.
Related Concept Videos
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Drug Metabolism: Phase II Reactions
Ligand Binding and Linkage
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

